GLYCTK: A Key Enzyme in The Glycolytic Pathway (G132158)

Target Name: GLYCTK

NCBI ID: G132158

GLYCTK

GLYCTK: A Key Enzyme in The Glycolytic Pathway

GLYCTK, also known as Glycerate kinase or transcript variant 2, is a protein that is expressed in various tissues throughout the body. It is a key enzyme in the glycolytic pathway, which is a critical pathway for cellular energy metabolism. GLYCTK is often used as a drug target or biomarker due to its unique structure and function.

GLYCTK is a 21-kDa protein that is expressed in the liver, muscle, and heart. It is highly conserved across various species, which indicates that it has a critical role in the evolution of the glycolytic pathway. GLYCTK is a key enzyme in the glycolytic pathway, as it catalyzes the conversion of glucose-6-phosphate (G6P) to glucose-6-pyruvate (G6P). This conversion is a critical step in the glycolytic pathway, as it allows for the production of ATP energy.

GLYCTK is a transmembrane protein, which means that it spans the cell membrane and is located in the cytoplasm. Its unique structure and function make it an attractive drug target or biomarker. GLYCTK has a unique catalytic mechanism, which involves a unique protein-protein interaction. The N-terminus of GLYCTK contains a conserved domain that is involved in protein-protein interaction. This domain is known as the ATP-binding domain, which is critical for GLYCTK's catalytic mechanism.

GLYCTK's catalytic mechanism involves a unique protein-protein interaction that is critical for its function. The N-terminus of GLYCTK contains a conserved domain that is involved in protein-protein interaction. This domain is known as the ATP-binding domain, which is critical for GLYCTK's catalytic mechanism. The ATP-binding domain is a key region that interacts with ATP to facilitate the catalytic reaction.

GLYCTK's catalytic mechanism involves a unique protein-protein interaction that is critical for its function. The N-terminus of GLYCTK contains a conserved domain that is involved in protein-protein interaction. This domain is known as the ATP-binding domain, which is critical for GLYCTK's catalytic mechanism. The ATP-binding domain is a key region that interacts with ATP to facilitate the catalytic reaction.

GLYCTK has been shown to play a critical role in various cellular processes, including metabolism, cell growth, and cell survival. GLYCTK has been shown to be involved in the regulation of cellular metabolism, including the production of ATP and the inhibition of the citric acid cycle. GLYCTK has also been shown to play a critical role in the regulation of cell growth and cell survival.

GLYCTK has been shown to play a critical role in various cellular processes, including metabolism, cell growth, and cell survival. GLYCTK has been shown to be involved in the regulation of cellular metabolism, including the production of ATP and the inhibition of the citric acid cycle. GLYCTK has also been shown to play a critical role in the regulation of cell growth and cell survival.

GLYCTK is often used as a drug target or biomarker due to its unique structure and function. Its unique catalytic mechanism and its involvement in various cellular processes make it an attractive target for drug development. GLYCTK has also been shown to play a critical role in the regulation of cellular metabolism, including the production of ATP and the inhibition of the citric acid cycle. These properties make GLYCTK an attractive drug target or biomarker for various diseases, including cancer, diabetes, and cardiovascular disease.

In conclusion, GLYCTK is a unique protein that is expressed in various tissues throughout the body. Its unique catalytic mechanism and its involvement in various cellular processes make it an attractive drug target or biomarker. GLYCTK has been shown to play a critical role in the regulation of cellular metabolism, including the production of ATP and the inhibition of the citric acid cycle. These properties make GLYCTK an attractive target for drug development for various diseases, including cancer, diabetes, and cardiovascular disease. Further research is needed to fully understand the unique mechanisms of GLYCTK and its role in the regulation of cellular processes.

Protein Name: Glycerate Kinase

The "GLYCTK Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GLYCTK comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets